Gemmer Asset Management LLC Edwards Lifesciences Corp Transaction History

Gemmer Asset Management LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$86.5 - $128.27 $27,074 - $40,148	-313 Closed	0 $0
Q1 2022 Apr 20, 2022	BUY	$101.96 - $128.34 $31,913 - $40,170	313 New	313 $36,000
Q3 2021 Oct 19, 2021	SELL	$102.91 - $122.75 $33,445 - $39,893	-325 Closed	0 $0
Q2 2021 Jul 23, 2021	BUY	$83.84 - $104.76 $1,509 - $1,885	18 Added 5.86%	325 $34,000
Q4 2020 Jan 28, 2021	SELL	$71.69 - $91.23 $2,867 - $3,649	-40 Reduced 11.53%	307 $28,000

Q3 2020 Oct 21, 2020	SELL	$67.19 - $87.44 $2,351 - $3,060	-35 Reduced 9.16%	347 $28,000
Q2 2020 Jul 31, 2020	BUY	$57.54 - $76.95 $14,787 - $19,776	257 Added 205.6%	382 $26,000
Q4 2019 Jan 17, 2020	SELL	$71.7 - $82.09 $143 - $164	-2 Reduced 1.57%	125 $29,000
Q3 2019 Oct 11, 2019	BUY	$61.55 - $75.43 $123 - $150	2 Added 1.6%	127 $28,000
Q2 2019 Jul 18, 2019	BUY	$55.74 - $64.41 $891 - $1,030	16 Added 14.68%	125 $23,000
Q1 2019 Apr 17, 2019	SELL	$47.89 - $64.05 $1,915 - $2,562	-40 Reduced 26.85%	109 $21,000
Q4 2017 Jan 16, 2018	BUY	$33.79 - $39.39 $1,250 - $1,457	37 Added 33.04%	149 $17,000
Q3 2017 Oct 12, 2017	BUY	$36.29 - $38.83 $4,064 - $4,348	112	112 $12,000

1,377

454M

3.86M

3.32M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $56.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Gemmer Asset Management LLC with notifications on news.